Skip to main content
Erschienen in: Cancer Microenvironment 3/2014

01.12.2014 | Original Paper

Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment

verfasst von: Muhammad Zaeem Noman, Yosra Messai, Jane Muret, Meriem Hasmim, Salem Chouaib

Erschienen in: Cancer Microenvironment | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Accumulating evidence indicate that the behavior of tumorigenic cells is highly influenced by their microenvironment. In this regard, microenvironmental hypoxia plays a determinant role in the emergence of CTC (circulating tumor cells) and CSC (cancer stem cells). CTCs are believed to be indicators of residual disease and thus pose an increased risk of metastasis. In spite of being rare and exposed to immune attack, these cells are capable to escape the immune system of the host. Although CTC play a pivotal role in the metastatic cascade and their prognostic impact has been repeatedly demonstrated, little is known about their escape mechanisms to immune system of the host. Therefore a better knowledge of the immunogenicity of these cells and their cross talk with immune killer cells as well as with tumor microenvironment may represent an exciting new immunotherapy opportunity. In this chapter, we will discuss how hypoxia is involved in the regulation of tumor progression and induction of EMT and cancer stem cell like features. We will also illustrate the relationship between hypoxia and CTC and review how CTC interact with the cells of immune system (both innate and adaptive) in terms of their survival and EMT phenotype. We will attempt to outline how hypoxic stress may confer resistance to CTC by giving them EMT and CSC like phenotype. Finally we will discuss whether the inhibition of hypoxic signaling pathways in different compartments of the solid tumor microenvironment will have an impact on CTC number, resistant phenotype and CTC lysis by immune effectors.
Literatur
1.
Zurück zum Zitat Akalay I, Janji B et al (2013) EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction. Autophagy 9(7):1104–1106PubMedCentralPubMedCrossRef Akalay I, Janji B et al (2013) EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction. Autophagy 9(7):1104–1106PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Apostolou P, Toloudi M et al (2012) Cancer stem cells stemness transcription factors expression correlates with breast cancer disease stage. Curr Stem Cell Res Ther 7(6):415–419PubMedCrossRef Apostolou P, Toloudi M et al (2012) Cancer stem cells stemness transcription factors expression correlates with breast cancer disease stage. Curr Stem Cell Res Ther 7(6):415–419PubMedCrossRef
4.
Zurück zum Zitat Baccelli I, Schneeweiss A et al (2013) Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31(6):539–544PubMedCrossRef Baccelli I, Schneeweiss A et al (2013) Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31(6):539–544PubMedCrossRef
5.
Zurück zum Zitat Blank C, Gajewski TF et al (2005) Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol Immunother 54(4):307–314PubMedCrossRef Blank C, Gajewski TF et al (2005) Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol Immunother 54(4):307–314PubMedCrossRef
6.
Zurück zum Zitat Brizel DM, Scully SP et al (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56(5):941–943PubMed Brizel DM, Scully SP et al (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56(5):941–943PubMed
7.
Zurück zum Zitat Derre L, Corvaisier M et al (2006) Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol 177(5):3100–3107PubMedCrossRef Derre L, Corvaisier M et al (2006) Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol 177(5):3100–3107PubMedCrossRef
8.
9.
Zurück zum Zitat Driemel, C., H. Kremling, et al. (2013). “Context-dependent adaption of EpCAM expression in early systemic esophageal cancer” Oncogene. Driemel, C., H. Kremling, et al. (2013). “Context-dependent adaption of EpCAM expression in early systemic esophageal cancer” Oncogene.
10.
Zurück zum Zitat Eliane JP, Repollet M et al (2008) Monitoring serial changes in circulating human breast cancer cells in murine xenograft models. Cancer Res 68(14):5529–5532PubMedCentralPubMedCrossRef Eliane JP, Repollet M et al (2008) Monitoring serial changes in circulating human breast cancer cells in murine xenograft models. Cancer Res 68(14):5529–5532PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Green TL, Cruse JM et al (2013) Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment. Exp Mol Pathol 95(2):174–179PubMedCrossRef Green TL, Cruse JM et al (2013) Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment. Exp Mol Pathol 95(2):174–179PubMedCrossRef
12.
Zurück zum Zitat Green TL, Santos MF et al (2014) Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells. Exp Mol Pathol 97(1):44–48PubMedCrossRef Green TL, Santos MF et al (2014) Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells. Exp Mol Pathol 97(1):44–48PubMedCrossRef
13.
Zurück zum Zitat Gruber I, Landenberger N et al (2013) Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer. Anticancer Res 33(5):2233–2238PubMed Gruber I, Landenberger N et al (2013) Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer. Anticancer Res 33(5):2233–2238PubMed
14.
Zurück zum Zitat Hamai A, Benlalam H et al (2010) Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune? Tissue Antigens 75(1):1–8PubMedCrossRef Hamai A, Benlalam H et al (2010) Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune? Tissue Antigens 75(1):1–8PubMedCrossRef
15.
Zurück zum Zitat Harris AL (2002) Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38–47PubMedCrossRef Harris AL (2002) Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38–47PubMedCrossRef
16.
Zurück zum Zitat Hasmim M, Noman MZ et al (2013) Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-beta1. J Immunol 191(12):5802–5806PubMedCrossRef Hasmim M, Noman MZ et al (2013) Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-beta1. J Immunol 191(12):5802–5806PubMedCrossRef
17.
Zurück zum Zitat Hoffmann AC, Warnecke-Eberz U et al (2007) Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers. J Surg Oncol 95(1):51–54PubMedCrossRef Hoffmann AC, Warnecke-Eberz U et al (2007) Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers. J Surg Oncol 95(1):51–54PubMedCrossRef
18.
Zurück zum Zitat Kallergi G, Markomanolaki H et al (2009) Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res 11(6):R84PubMedCentralPubMedCrossRef Kallergi G, Markomanolaki H et al (2009) Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res 11(6):R84PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Kallergi G, Papadaki MA et al (2011) Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res 13(3):R59PubMedCentralPubMedCrossRef Kallergi G, Papadaki MA et al (2011) Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res 13(3):R59PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Konishi J, Yamazaki K et al (2004) B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res 10(15):5094–5100PubMedCrossRef Konishi J, Yamazaki K et al (2004) B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res 10(15):5094–5100PubMedCrossRef
22.
Zurück zum Zitat Kudo-Saito C, Shirako H et al (2009) Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15(3):195–206PubMedCrossRef Kudo-Saito C, Shirako H et al (2009) Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15(3):195–206PubMedCrossRef
23.
Zurück zum Zitat Lau KW, Tian YM et al (2007) Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. Br J Cancer 96(8):1284–1292PubMedCentralPubMedCrossRef Lau KW, Tian YM et al (2007) Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. Br J Cancer 96(8):1284–1292PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Liu S, Li N et al (2013) "Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.". Gastroenterology 144(5):1031–1041PubMedCrossRef Liu S, Li N et al (2013) "Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.". Gastroenterology 144(5):1031–1041PubMedCrossRef
26.
Zurück zum Zitat Makino Y, Uenishi R et al (2007) Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. J Biol Chem 282(19):14073–14082PubMedCrossRef Makino Y, Uenishi R et al (2007) Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. J Biol Chem 282(19):14073–14082PubMedCrossRef
27.
Zurück zum Zitat Malmberg KJ, Levitsky V et al (2002) IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J Clin Invest 110(10):1515–1523PubMedCentralPubMedCrossRef Malmberg KJ, Levitsky V et al (2002) IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J Clin Invest 110(10):1515–1523PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Marincola FM, Jaffee EM et al (2000) Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74:181–273PubMedCrossRef Marincola FM, Jaffee EM et al (2000) Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74:181–273PubMedCrossRef
29.
Zurück zum Zitat Medema JP, de Jong J et al (2001) Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci U S A 98(20):11515–11520PubMedCentralPubMedCrossRef Medema JP, de Jong J et al (2001) Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci U S A 98(20):11515–11520PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6(6):449–458PubMedCrossRef Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6(6):449–458PubMedCrossRef
31.
Zurück zum Zitat Noman MZ, Messai Y et al (2011) Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response. Crit Rev Immunol 31(5):357–377PubMedCrossRef Noman MZ, Messai Y et al (2011) Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response. Crit Rev Immunol 31(5):357–377PubMedCrossRef
32.
Zurück zum Zitat Pardal R, Clarke MF et al (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3(12):895–902PubMedCrossRef Pardal R, Clarke MF et al (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3(12):895–902PubMedCrossRef
33.
Zurück zum Zitat Raimondi C, Gradilone A et al (2011) Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res Treat 130(2):449–455PubMedCrossRef Raimondi C, Gradilone A et al (2011) Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res Treat 130(2):449–455PubMedCrossRef
34.
Zurück zum Zitat Reya T, Morrison SJ et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105–111PubMedCrossRef Reya T, Morrison SJ et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105–111PubMedCrossRef
35.
Zurück zum Zitat Salceda S, Caro J (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272(36):22642–22647PubMedCrossRef Salceda S, Caro J (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272(36):22642–22647PubMedCrossRef
36.
Zurück zum Zitat Schulze K, Gasch C et al (2013) Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int J Cancer 133(9):2165–2171PubMedCrossRef Schulze K, Gasch C et al (2013) Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int J Cancer 133(9):2165–2171PubMedCrossRef
37.
Zurück zum Zitat Semenza GL (2009) HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery. Curr Pharm Des 15(33):3839–3843PubMedCrossRef Semenza GL (2009) HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery. Curr Pharm Des 15(33):3839–3843PubMedCrossRef
38.
Zurück zum Zitat Smith HA, Kang Y (2013) The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) 91(4):411–429CrossRef Smith HA, Kang Y (2013) The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) 91(4):411–429CrossRef
39.
Zurück zum Zitat Steinert G, Scholch S et al (2014) Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. Cancer Res 74(6):1694–1704PubMedCrossRef Steinert G, Scholch S et al (2014) Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. Cancer Res 74(6):1694–1704PubMedCrossRef
40.
Zurück zum Zitat Theodoropoulos PA, Polioudaki H et al (2010) Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 288(1):99–106PubMedCrossRef Theodoropoulos PA, Polioudaki H et al (2010) Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 288(1):99–106PubMedCrossRef
41.
Zurück zum Zitat Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442–454PubMedCrossRef Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442–454PubMedCrossRef
42.
Zurück zum Zitat Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131–142PubMedCrossRef Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131–142PubMedCrossRef
43.
Zurück zum Zitat Tinhofer I, Saki M et al (2014) Cancer stem cell characteristics of circulating tumor cells. Int J Radiat Biol 1–6 Tinhofer I, Saki M et al (2014) Cancer stem cell characteristics of circulating tumor cells. Int J Radiat Biol 1–6
44.
Zurück zum Zitat Vander Griend DJ, Karthaus WL et al (2008) The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 68(23):9703–9711PubMedCentralPubMedCrossRef Vander Griend DJ, Karthaus WL et al (2008) The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 68(23):9703–9711PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Vegran F, Boidot R (2013) Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and −6 in cancer cells. Oncoimmunology 2(11):e26328PubMedCentralPubMedCrossRef Vegran F, Boidot R (2013) Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and −6 in cancer cells. Oncoimmunology 2(11):e26328PubMedCentralPubMedCrossRef
46.
Zurück zum Zitat Wang GL, Jiang BH et al (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92(12):5510–5514PubMedCentralPubMedCrossRef Wang GL, Jiang BH et al (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92(12):5510–5514PubMedCentralPubMedCrossRef
47.
48.
Zurück zum Zitat Wohlfart S, Sebinger D et al (2004) FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol 164(3):1081–1089PubMedCentralPubMedCrossRef Wohlfart S, Sebinger D et al (2004) FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol 164(3):1081–1089PubMedCentralPubMedCrossRef
49.
Zurück zum Zitat Yie SM, Luo B et al (2006) Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Clin Exp Metastasis 23(5–6):279–289PubMedCrossRef Yie SM, Luo B et al (2006) Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Clin Exp Metastasis 23(5–6):279–289PubMedCrossRef
50.
Zurück zum Zitat Yu M, Bardia A et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584PubMedCentralPubMedCrossRef Yu M, Bardia A et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584PubMedCentralPubMedCrossRef
Metadaten
Titel
Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment
verfasst von
Muhammad Zaeem Noman
Yosra Messai
Jane Muret
Meriem Hasmim
Salem Chouaib
Publikationsdatum
01.12.2014
Verlag
Springer Netherlands
Erschienen in
Cancer Microenvironment / Ausgabe 3/2014
Print ISSN: 1875-2292
Elektronische ISSN: 1875-2284
DOI
https://doi.org/10.1007/s12307-014-0157-3

Weitere Artikel der Ausgabe 3/2014

Cancer Microenvironment 3/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.